MIM
INTT icon

MetLife Investment Management’s inTEST INTT Stock Holding History

MetLife Investment Management’s Portfolio INTT Stock Details INTT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$128K Buy
+7,053
New +$119K ﹤0.01% 2657
2024
Q2 		– Sell
-5,694
Closed -$75.4K – 2905
2024
Q1 		$75.4K Hold
5,694
– – ﹤0.01% 2650
2023
Q4 		$77.4K Hold
5,694
– – ﹤0.01% 2704
2023
Q3 		$86.4K Hold
5,694
– – ﹤0.01% 2653
2023
Q2 		$150K Buy
+5,694
New +$126K ﹤0.01% 2441

Other funds holding INTT

RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PRCP
Pacific Ridge Capital Partners Lake Oswego, Oregon $551M AUM 49.99% 1-Year Est. Return

MetLife Investment Management's INTT Position: Q2 2026 in Review

MetLife Investment Management opened a new position in inTEST (INTT) in Q2 2026: 7,053 shares worth $128K. The stake represents ﹤0.01% of the portfolio and ranks #2657 among its holdings. This is a return to the name: MetLife Investment Management previously reported a position in INTT as recently as Q1 2024.

MetLife Investment Management first reported a position in INTT in Q2 2023 and has held it in 5 quarters since. The position peaked at $150K in Q2 2023. 90 funds tracked by Wall St. Rank hold INTT as of Q2 2026.

  • MetLife Investment Management held 7,053 shares of inTEST worth $128K as of Q2 2026.
  • inTEST was a new MetLife Investment Management position in Q2 2026.
  • inTEST made up ﹤0.01% of MetLife Investment Management's portfolio in Q2 2026, its #2657 holding.
  • MetLife Investment Management first reported a position in inTEST in Q2 2023 and has held it in 5 quarters since.
  • MetLife Investment Management's inTEST position peaked at $150K in Q2 2023.
  • 90 funds tracked by Wall St. Rank held inTEST as of Q2 2026.

Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.